コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 EBER(I) (from Epstein-Barr) and VA(I) (from human adenovirus).
2 I) (from Epstein-Barr virus) and VA(I) (from human adenovirus).
3 DNA viruses mouse cytomegalovirus (MCMV) and human adenovirus.
4 y resembles hexon, the equivalent protein in human adenovirus.
5 these are limited by preexisting immunity to human adenoviruses.
6 s disease burden results from infection with human adenoviruses.
7 PCR using primers designed to amplify known human adenoviruses.
8 detection, identification, and serotyping of human adenoviruses.
9 understanding of pathoepidemiology among the human adenoviruses.
10 d-type and replication-incompetent bovine or human adenoviruses.
11 found to be similar in overall structure to human adenoviruses.
12 , PLDLS, conserved among the E1A proteins of human adenoviruses.
13 at may contribute to persistent infection by human adenoviruses.
14 associated antigen presentation proposed for human adenoviruses.
15 gnaling, a function found to be conserved by human adenoviruses.
16 ent life cycles in these genetically distant human adenoviruses.
17 he latter activity of which was conserved by human adenoviruses.
18 disease (ARD) associated with subspecies B2 human adenovirus 11a (HAdV-11a) infection were detected
19 atory disease (ARD) among military recruits, human adenovirus 14 (HAdV-14) has historically been cons
20 and H10N8; variant influenza A H3N2 virus), human adenovirus-14, and Middle East respiratory syndrom
22 identical to that of the prototype strain of human adenovirus 16 [HAdV-16], Ch79) was isolated in Arg
24 ndicate that the E4ORF1 peptide derived from human adenovirus 36 (Ad36) interacts with cells from adi
25 nucleotide sequences with a high homology to human adenovirus 41 (HAdV-41) and simian adenovirus 1 (S
26 lification reaction of DNA from two viruses (Human adenovirus 41, Phi X 174) and the bacterium Entero
27 (+/-19)%, as model organism, as well as for human adenoviruses 42.4 (+/-3.4)% and murine noroviruses
28 s) by inoculation of a replication-defective human adenovirus 5 (Ad5) vector expressing IFNs can effe
29 -gamma) delivered by a replication-defective human adenovirus 5 (Ad5) vector protected swine when cha
31 cells with a replication-competent strain of human adenovirus 5 (Ad5dl309) results in cytotoxicity.
32 derived from common human serotypes, such as human adenovirus 5 (AdHu5), is the high prevalence of vi
34 ur unbiased proteomic analysis revealed that human adenovirus 5 (HAdv5) L-E1A was associated with man
35 endent neutralizing antibody in complex with human adenovirus 5 hexon and show how these properties i
37 bovine migrating DC to show that recombinant human adenovirus 5 vectors efficiently transduce afferen
38 ed five immunization strategies that include Human adenovirus-5 (AdHu5), Chimpanzee adenovirus-6 (AdC
39 edicted to encode proteins homologous to the human adenovirus (Ad) 100-kDa, 33kDa and DNA-binding pro
47 s to the fiber gene that could differentiate human adenovirus (Ad) species A through F in a single am
48 g a variety of mammalian pathogens including human adenovirus (Ad), whose genomes encode a gene for m
60 nfection of non-enveloped viruses, including human adenoviruses (AdV), papillomaviruses (HPV), and po
61 apability of this approach to rapidly type a human adenovirus and several strains of human rhinovirus
62 ubiquitous source of polymorphic markers for human adenoviruses and demonstrates their use through an
64 on of herpes simplex virus 1 (HSV-1), HSV-2, human adenovirus, and human cytomegalovirus in cultured
65 rs are susceptible to infection with certain human adenoviruses, and the pathology accompanying these
67 basis of these results, it is proposed that human adenoviruses are potentially useful for cancer gen
71 munogenic, providing a viable alternative to human adenoviruses as vaccine vectors for human use.
72 transmembrane-containing proteins encoded by human adenoviruses, as a model system to survey the extr
73 cteriophage PRD1 and the double-stranded DNA human adenoviruses, as well as the viral proteins VP2-VP
74 G and IgM antibodies against influenza A and human adenoviruses based on the color and position of th
75 nt-like models that allow direct analysis of human adenovirus-based conditionally replicative adenovi
76 Adenovirus type 9 (Ad9) is distinct among human adenoviruses because it elicits solely mammary tum
78 that human defensin HD5 inactivates specific human adenoviruses by binding to capsid proteins and blo
79 ction limits of 1 x 10(3) virus particles of Human adenovirus C (HAdV), Human astrovirus (HAstV), and
82 in encoded by the E3 transcription region of human adenoviruses called E3-13.7, which diverts recycli
83 show that recombinant replication-defective human adenovirus can transfect primary cardiac cultures
86 mpared with known E3 sequences of most other human adenoviruses deposited in GenBank, the sequences o
87 immunodeficient xenograft tumor models since human adenoviruses do not replicate effectively in murin
89 We have recently shown that E1A protein of human adenovirus downregulates epidermal growth factor r
90 n chimpanzee adenovirus vectors from species Human adenovirus E (ChAdOx1 and AdC68) in mice, though t
102 4 ORF1 and dUTPase proteins, we propose that human adenovirus E4 ORF1 genes have evolved from an ance
103 a genomic location analogous to that of the human adenovirus E4 ORF1s, was a genuine dUTPase enzyme.
104 Our findings indicate that most, if not all, human adenovirus E4-ORF1 proteins share a conserved mole
105 was carried out to investigate whether other human adenovirus E4-ORF1 proteins share this mechanism o
106 human T-cell leukemia virus type 1 Tax, and human adenovirus E4-ORF1, the functional consequences fo
111 A549 (an epithelial-like cell line) using a human adenovirus expressing a beta-galactosidase reporte
112 udy was to alter the broad native tropism of human adenovirus for virus targeting to c-erbB2-positive
120 timicrobial peptides capable of neutralizing human adenovirus (HAdV) in vitro by binding capsid prote
125 however, an appropriate viral surrogate for human adenovirus (HAdV), a medium-sized virus with a dou
126 ange of waterborne viral pathogens including human adenovirus (HAdV), but the mechanisms by which fre
127 ay has improved sensitivity for detection of human adenovirus (HAdV), compared to an earlier version
128 vity of NVC-422 against several serotypes of human adenovirus (HAdV), coxsackievirus A24, enterovirus
129 For viruses that lack envelopes, such as human adenovirus (HAdV), other, less well defined, mecha
144 We have recently reported that a group of human adenoviruses (HAdVs) uses desmoglein 2 (DSG2) as a
145 The recent emergence of highly virulent human adenoviruses (HAdVs) with new tissue tropisms unde
147 myocarditis, and the species specificity of human adenoviruses has limited the development of animal
148 eak of pneumonia associated with an emerging human adenovirus (human adenovirus serotype 14 [HAdV-14]
150 t time, we report that E4-ORF1 proteins from human adenoviruses in subgroups A to D evolved a conserv
151 adenoviruses differ substantially from other human adenoviruses in their host range; i.e., they repli
152 ly detect a wide range of known serotypes of human adenovirus, including all of subgroups A to C.
153 ithin rhesus macaques is complicated because human adenoviruses, including human adenovirus type 5 (H
157 ted in fatal disseminated disease resembling human adenovirus infections in immunocompromised patient
163 tribute of the E4-ORF3 proteins of different human adenoviruses is the ability to disrupt PML nuclear
164 demonstrate that the 5' noncoding region of human adenovirus late mRNAs, known as the tripartite lea
165 g suggests that immune evasion strategies of human adenoviruses may be directed, in part, toward prot
166 Genes within the E3 transcription unit of human adenoviruses modulate host immune responses to inf
167 We used MAV-1 to establish a mouse model of human adenovirus myocarditis, providing the means to stu
175 tein of bacteriophage PRD1 resembles that of human adenovirus raised the unexpected possibility that
177 immunocompetent model that is permissive to human adenovirus replication in tumors as well as normal
179 endent pathway through which the E1A gene of human adenovirus sensitizes mouse and human cells to apo
180 ssociated with an emerging human adenovirus (human adenovirus serotype 14 [HAdV-14]) occurred on a ru
181 (i) the discovery of a new mechanism used by human adenovirus serotype 3 to overcome innate antiviral
182 es that priming with a replication-defective human adenovirus serotype 35 (Ad35) vector encoding circ
185 ulated plasmid DNA and replication-defective human adenovirus serotype 5 (Ad5) vaccine vectors expres
187 o-associated virus serotype 6 (AAV-po6), and human adenovirus serotype 5 (Ad5) vector, in a short-ter
191 , we describe the development of recombinant human adenovirus serotype 5 and modified vaccinia virus
193 e was used to boost Ab responses primed by a human adenovirus serotype 5 vaccine recombinant for the
197 -associated (VA) RNA species of all 47 known human adenovirus serotypes and of one simian virus, SA7.
198 f E4-ORF1 proteins encoded by representative human adenovirus serotypes from subgroups A to D induce
199 y affected by preexisting immunity to common human adenovirus serotypes, such as 2, 4, 5, 7, and 12.
201 d that desmoglein 2 (DSG2) is a receptor for human adenovirus species B serotypes Ad3, Ad7, Ad11, and
202 E3 transcription unit for 38 viruses within human adenovirus species D (HAdV-D) revealed distinct an
205 Humans are infected by common serotypes of human adenovirus such as AdHu5 early in life and a signi
207 (simian adenoviruses) rather than with other human adenoviruses, suggesting a recent origin of HAdV-4
208 MPORTANCE Early region 3 proteins encoded by human adenoviruses that attenuate immune-mediated pathol
209 w adenovirus was so divergent from the known human adenoviruses that it was not only a new type but a
213 viruses (CVB) cause human myocarditis, while human adenovirus type 2 (Ad2) is implicated as an agent
220 uences for open reading frames (ORFs) of the human adenovirus type 41 (Ad41) early region 3 (E3) gene
225 opy, we have determined the structure of the human adenovirus type 5 (Ad5) to 3.6-A resolution and ha
226 le using a recombinant replication-defective human adenovirus type 5 (Ad5) vector, Ad5-boIFN-lambda3,
227 -molecular-weight (100K) assembly protein of human adenovirus type 5 (Ad5-100K) was previously define
228 structed a humanized monoclonal IgG1 against human adenovirus type 5 (AdV5) and a panel of Fc-enginee
230 icated because human adenoviruses, including human adenovirus type 5 (HAdV-5), are not endogenous to
231 ry of the pro-apoptotic gene PUMA to FLS via human adenovirus type 5 (HAdV5) vectors has been tested
232 ansforming human embryonic kidney cells with human adenovirus type 5 (HAV5) early region 1 (E1) seque
234 ctron counting, we improved the structure of human adenovirus type 5 and confirmed our previous model
235 cted by an E1B 55-kDa protein-null mutant of human adenovirus type 5 carry a large number of posttran
237 eered DNA plasmids and replication-deficient human adenovirus type 5 constructs encoding large sectio
238 ontrast, infection with influenza B virus or human adenovirus type 5 did not induce significant level
239 in to investigate the mechanism by which the human adenovirus type 5 E1B 55-kDa protein protects agai
241 ture, and swine inoculated with 10(9) PFU of human adenovirus type 5 expressing porcine IFN-alpha (Ad
243 e observation that the early region (E1A) of human adenovirus type 5 is directly linked to and may in
245 tem fabricated to deliver a live recombinant human adenovirus type 5 vaccine vector (AdHu5) encoding
247 nstructed recombinant, replication-defective human adenovirus type 5 vectors containing either porcin
249 evaluate its efficacy, an adenovirus vector (human adenovirus type 5) encoding a green fluorescent pr
250 VA (Modified Vaccinia virus Ankara) and Ad5 (human adenovirus type 5) vectors both expressing Ag85A i
251 viral protein expression and replication by human adenovirus type 5, and dysregulates cellular gluco
254 (epidemic period) 85% of typed isolates were human adenovirus type 8 (HAdV-D8), whereas only low leve
261 of estrogen-dependent rat mammary tumors by human adenovirus type 9 (Ad9) requires the Ad9 E4 open r
262 ssential oncogenic determinant of subgroup D human adenovirus type 9 (Ad9), which uniquely elicits es
264 ted that the E4-ORF1 protein from subgroup D human adenovirus type 9 upregulates and oncogenically ac
265 ediates oncogenic cellular transformation by human adenovirus type 9, augments viral protein expressi
266 , 50, and 50 genomic copies per reaction for human adenovirus type B3 (HAdV-B3), HAdV-E4, HAdV-B7, HA
267 ermined in triplicate assays by incubating 9 human adenovirus types (1, 2, 3, 4, 5, 7a, 8, 19, and 37
269 le recombinant integrin alphavbeta5 bound to human adenovirus types 2 and 12 (Ad2 and -12) has been d
274 IFN-alpha/beta) with a replication-defective human adenovirus vector (adenovirus 5 [Ad5]) can sterile
275 vestigations of the efficiency and safety of human adenovirus vector (AdV)-mediated gene transfer in
277 Here, we report the structure of the whole human adenovirus virion at 3.6 angstroms resolution by c
283 replication of P1/HRV2 in mice, recombinant human adenoviruses were used to express bicistronic mRNA
284 nslation and poliovirus tropism, recombinant human adenoviruses were used to express bicistronic mRNA
285 to show that pVIn is associated with mature human adenovirus, where it binds at the base of peripent
286 d by the immunologic heterogeneity of the 51 human adenoviruses, which are grouped from A to F on the
287 ry using a replication-defective recombinant human adenovirus with an early large T-antigen, had a mu
288 length and is most similar to subgroup E of human adenovirus, with 90% identity in most adenovirus t
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。